PKD1 and type 2 diabetes mellitus: Our data support a positive regulatory role for both P2Y1 and PKD1, particularly in obese (but nondiabetic) donors, suggesting a role for this pathway in compensatory upregulation of insulin secretion and that disruption of P2Y1‐PKD1 signaling may promote β cell dysfunction in type 2 diabetes.